Hydroxychloroquine vs. methotrexate for frontal fibrosing alopecia
Treatments studied
Part of Skin clinical trials.
This trial compares two common medicines, hydroxychloroquine and methotrexate, to see which works better for treating frontal fibrosing alopecia (a type of hair loss). You and your doctor can choose which treatment you prefer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older
- You have been diagnosed with frontal fibrosing alopecia (FFA)
- You are able to read and understand Dutch
- You have no known allergies or medical reasons that prevent you from taking hydroxychloroquine or methotrexate
- You are willing to take the medicine, attend clinic visits, and fill out questionnaires
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two medications, hydroxychloroquine and methotrexate, to see which works better for treating lichen planopilaris (a scalp condition that causes hair loss). Patients can choose their treatment or be assigned based on their health needs.
This trial tests a cream called delgocitinib to see if it can reduce redness and scaling in people with frontal fibrosing alopecia, a type of hair loss. It may help improve your symptoms if other treatments haven't worked.
This study tests whether laser therapy can help treat small bumps (papules) that appear on the face in people with frontal fibrosing alopecia, a type of hair loss. If you have these bumps and are generally healthy, you may be able to join.
This study compares two medicines, cyclosporine and methotrexate, to see which works better for children with alopecia areata (a condition causing hair loss). It aims to help doctors choose the best treatment for each child.
This trial compares two medications, tofacitinib and methotrexate, to see which works better for severe hair loss caused by alopecia areata. If you have severe alopecia areata (total or universal hair loss), this study may offer a chance to try a new treatment option.
This study tests if a cream containing methotrexate (a medicine that affects the immune system) can help regrow hair in people with mild alopecia areata (patchy hair loss on the scalp). It compares the methotrexate cream to a standard treatment cream (minoxidil) to see which works better.
Hear when a new Frontal Fibrosing Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.